Day 1 | Day 2
Wednesday, 4 August 2021
The rise of non-traditional capital in Southeast Asia
Non-traditional capital held by family offices, corporate investment arms and sovereign wealth funds is slowly but surely becoming a major player in the Southeast Asia investment landscape, particularly in tech. According to Bain & Company, they were involved in over 65% or PE deals across the region in 2019 and that numbers is likely to be even higher in 2020 as their investment continued throughout the pandemic. Our experts discuss the merits and challenges of working with this patient capital.
- What are the benefits of using sources of non-traditional capital?
- What challenges are organisations facing when transacting with non-traditional capital?
- Does working with corporate investors limit the scope for financial returns and exits?
- How does private equity and venture capital view working with patient capital?
Networking coffee break
The next step on the ESG journey
Sustainability, ESG and impact investing are on their way to mainstream considerations in Southeast Asian private equity. For some GPs It has become a fundamental element of the investment process and the pandemic has brought to the fore the need for business to have sound ESG practices to remain robust. Leading GPs and LPs discuss their views and approach when it comes to ESG and the challenges ahead for wider acceptance of ESG in private equity in the region.
- What are LP’s expectations from GP in terms of ESG practices?
- Has the pandemic hastened the ESG acceptance in PE strategies?
- Is ESG becoming a value and differentiation driver for GPs?
- How does a GP effectively implement and manage ESG across their entire portfolio?
LP view: The way forward
As limited partners increase their exposure to Asia, Southeast Asia as a region continues to attract interest but not necessarily the same level of allocation as other geographies on the continent. Whether this can change partly depends on improving the track record, team stability and succession, and strategies employed by GPs. Global LPs with presence in the region share their view on the way forward.
- Are LPs increasing their exposure to the region?
- What are the benefits and downsides of large GPs creating multi-product platforms?
- Is ESG playing a larger role in asset allocation decisions?
- Has COVID-19 prompted changes in strategy at the LP level?
In an interactive format with limited participants, subject matter experts will discuss and share their approach, strategies and war stories in tackling operational and investment challenges and preparing for the future. Topics include:
- Fundraising in the current environment
- Secondaries and deal flow
- Finding balance between growth and profitability
- SPACS case study
- Managing the changing regulatory landscape
Close of day two conference
An error occurred trying to play the stream. Please reload the page and try again.Close